Fulcrum Therapeutics (FULC) Stock Chart & Stock Price History $3.22 +0.25 (+8.42%) (As of 01:24 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Fulcrum Therapeutics Stock Price Performance 5 Day Performance+7.15%1 Month Performance-5.01%3 Month Performance-63.37%6 Month Performance-58.24%Year-To-Date Performance-52.30%1 Year Performance-29.23% Receive FULC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Fulcrum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address [Charles Payne Live Event] Click to Confirm Your RSVP (Ad)The Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about CLICK HERE TO RSVP FULC Stock Chart for Friday, November, 22, 2024 FULC Chart by TradingView Fulcrum Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/21/2024$2.99$2.97-0.67%$3.08$2.96460,986 shs$160.20 million11/20/2024$3.01$2.99-0.66%$3.06$2.96782,323 shs$161.28 million11/19/2024$3.03$3.01-0.66%$3.03$2.87725,505 shs$162.36 million11/18/2024$3.01$3.03+0.83%$3.10$2.932.36 million shs$163.44 million11/15/2024$3.32$3.01-9.49%$3.30$2.951.28 million shs$187.51 million11/14/2024$3.56$3.32-6.74%$3.56$3.28653,750 shs$207.17 million Get the Latest News and Ratings for FULC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fulcrum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/13/2024$3.64$3.56-2.20%$3.94$3.52870,143 shs$222.14 million11/12/2024$3.64$3.64$3.82$3.54873,268 shs$227.14 million11/11/2024$3.49$3.64+4.30%$3.72$3.52657,349 shs$227.14 million11/08/2024$3.48$3.49+0.29%$3.53$3.38502,216 shs$217.78 million11/07/2024$3.43$3.48+1.46%$3.63$3.421.16 million shs$217.15 million11/06/2024$3.32$3.43+3.31%$3.47$3.241.58 million shs$214.04 million11/05/2024$3.26$3.32+1.84%$3.35$3.21989,213 shs$207.17 million11/04/2024$3.21$3.26+1.56%$3.38$3.13843,613 shs$203.42 million11/01/2024$3.16$3.21+1.58%$3.22$3.14420,704 shs$200.30 million10/31/2024$3.24$3.16-2.47%$3.28$3.13433,545 shs$197.19 million10/30/2024$3.24$3.24$3.30$3.19428,895 shs$202.18 million10/29/2024$3.24$3.24$3.31$3.20340,482 shs$202.18 million10/28/2024$3.19$3.24+1.57%$3.30$3.21696,064 shs$202.18 million10/25/2024$3.24$3.19-1.54%$3.30$3.17509,622 shs$198.27 million10/24/2024$3.25$3.24-0.31%$3.33$3.22361,149 shs$201.38 million10/23/2024$3.39$3.25-4.13%$3.46$3.18899,614 shs$202 million10/22/2024$3.51$3.39-3.42%$3.56$3.36541,078 shs$210.70 million10/21/2024$3.51$3.51$3.59$3.49503,663 shs$218.16 million Related Companies BLUE Stock Chart KZR Stock Chart SGMO Stock Chart EXAI Stock Chart CRMD Stock Chart STOK Stock Chart ALT Stock Chart DNTH Stock Chart OCS Stock Chart IMNM Stock Chart Receive FULC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Fulcrum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:FULC) was last updated on 11/22/2024 by MarketBeat.com Staff From Our PartnersFinancial Prophecy The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored[Charles Payne Live Event] Click to Confirm Your RSVPThe Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about Unstoppable Prosperity | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredBREAKING: NVDA loses $175 billion in 8 minutesIt's a wild week for the legendary chipmaker. Nvidia just beat earnings expectations across every metric, w...Chaikin Analytics | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fulcrum Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fulcrum Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free fulc Stock Alerts